Cardiac POC is a medical test performed near to the site of the patient. The Cardiac POCs are simple medical blood tests that include cholesterol and coagulation testing. Cardiac POC tests include Troponin and brain natriuretic peptide tests, which are used to diagnose cardiovascular conditions such as acute myocardial infarction, coronary syndromes and heart failure. These tests help in the detection of enzymes released during failure of the heart and in critical cardiac conditions such as creating kinase, troponin, lactate dehydrogenase isoenzymes and brain natriuretic peptides.
The Cardiac POC tests helps to understand and differentiate better between myocardial infarction and angina, which help to diagnose the patient for a specific disease. These tests or assays offer reliable measurement of the markers, released during heart failure, and provide results within one hour of testing. In addition, to save time, a few Cardiac POC tests have been modified to measure enzymes to reduce operational error and simplify performance. Thus, these tests help significantly in reducing the turnaround time from testing to end results by allowing immediate patient response and effective treatment, or the discharge of patients.
The analysts forecast the Global Cardiac POC market will grow at a CAGR of 14.40 percent over the period 2013-2018.
This report covers the present scenario and growth prospects of the Global Cardiac POC market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of two type of tests: Troponin and brain natriuretic peptide tests, which are used to treat Cardiac POC. Furthermore, the report considers revenue generated from the following type of tests - Biosite Triage, Cobas and i-STAT.
The report also presents the vendor landscape and a corresponding detailed analysis of the top three vendors in the Global Cardiac POC market. In addition, it discusses the major drivers that influence the growth of the Global Cardiac POC market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market.
The report, the Global Cardiac POC Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Cardiac POC market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Vendors in the market are focusing on the introduction of new enhanced products to meet the needs of customers, providing better services in the diagnosis. The Healthcare industry takes a significant amount of time from the designing to its product launch. In addition, emerging technology in the Medical Diagnostics industry leads to an increase in competition among vendors, resulting in the development of new products in the market.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
06. Market Landscape
07. Market Segmentation by Type of Tests
08. Global Cardiac Troponin Test Market
09. Global Cardiac BNP Test Market
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
19. Key Vendor Analysis
- Alere Inc.
- Abbott Laboratories
- Roche Diagnostics
- Beckman Coulter
- BG Medicine Inc.
- Boston Scientific Corp
- Medtronic Inc.
- Randox Laboratories Ltd.
For more information visit http://www.researchandmarkets.com/research/b2tkls/global_cardiac
Media Contact: Laura Wood, +353-1-481-1716, email@example.com
SOURCE Research and Markets